RG6697
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 20, 2026
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
(clinicaltrials.gov)
- P1 | N=93 | Recruiting | Sponsor: Genentech, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Diabetic Macular Edema • Ophthalmology
1 to 1
Of
1
Go to page
1